The Mydayis Shortage in 2026: Where Things Stand

If you take Mydayis for ADHD, you've likely experienced the frustration of hearing "out of stock" from your pharmacy — again. The amphetamine shortage that began in late 2022 has dragged on longer than anyone expected, and patients who rely on Mydayis have been caught in the middle.

In this update, we'll cover the current state of the shortage, what's changed, how much Mydayis costs in 2026, and what options are available to help you stay on track with your treatment.

Is Mydayis Still in Shortage?

Yes. As of early 2026, amphetamine extended-release products — including Mydayis — remain in shortage. The American Society of Health-System Pharmacists (ASHP) continues to list multiple strengths and formulations as being on back order from various manufacturers.

That said, the situation has improved compared to the worst of the shortage in 2023-2024. The DEA increased amphetamine production quotas in fall 2025, which has allowed manufacturers to produce more. But production increases take time to flow through the supply chain, and demand continues to outpace supply for some formulations.

Mydayis is particularly affected because it's a niche product. Unlike generic Adderall XR, which dozens of manufacturers produce, Mydayis has fewer suppliers. When the overall amphetamine supply is tight, Mydayis tends to be one of the hardest products to find.

Why Is Mydayis Hard to Find?

The shortage comes down to several interconnected factors:

• DEA production quotas: As a Schedule II controlled substance, the amount of amphetamine that can be manufactured each year is capped by the DEA. Even after the 2025 quota increase, production hasn't fully met demand.
• Manufacturing delays: The original shortage was triggered in part by production issues at major generic manufacturers. Recovery has been gradual.
• Rising demand: ADHD diagnoses have increased significantly in recent years, particularly among adults. More prescriptions means more demand on a limited supply.
• Niche status: Mydayis is prescribed less often than Adderall XR or Vyvanse, so pharmacies are less likely to keep it in regular stock.

For a deeper dive, read our article on why Mydayis is so hard to find.

How Much Does Mydayis Cost in 2026?

Cost remains a significant concern for many patients, especially those without good insurance coverage.

Brand-name Mydayis

The retail cash price for a 30-day supply of brand-name Mydayis ranges from $345 to $466, depending on the strength and pharmacy.

Generic Mydayis

The FDA has approved generic versions of Mydayis (mixed amphetamine salts extended-release). When available, the generic version costs significantly less:

• With a GoodRx coupon: As low as $92 to $150 for a 30-day supply
• Without discounts: Around $200-$350

However, generic availability is inconsistent due to the shortage. You may find that the generic is even harder to locate than the brand in some areas.

Insurance coverage

Most insurance plans cover Mydayis, but often with restrictions:

• Prior authorization is commonly required
• Step therapy may be required — meaning you need to try a less expensive medication (like generic Adderall XR) first
• Brand Mydayis may be on a Tier 3 or specialty tier, meaning higher copays

For tips on reducing your costs, see our guide on how to save money on Mydayis.

New Options and Developments in 2026

While there's no single breakthrough that's solved the shortage, several positive developments have occurred:

• DEA quota increases: The DEA officially increased production quotas for amphetamine medications in fall 2025, allowing manufacturers to produce more
• Generic competition: FDA approval of generic Mydayis has added another potential source of supply, though actual pharmacy availability remains inconsistent
• Telehealth prescribing: Many prescribers now offer telehealth appointments, making it easier to get a new prescription sent to whichever pharmacy has stock
• Pharmacy locator tools: Services like Medfinder make it much easier to find pharmacies with current availability

How to Find Mydayis in Stock

Here are the most effective strategies for locating Mydayis right now:

1. Use Medfinder: Medfinder.com lets you search for pharmacies near you that currently have Mydayis in stock. It's free and regularly updated.
2. Try independent pharmacies: They often have more flexibility in sourcing medications from multiple wholesalers.
3. Time your search: Call pharmacies early in the month and mid-week (Tuesday-Thursday), when deliveries are most likely.
4. Ask about different strengths: Your doctor may be able to adjust your prescription if one strength is available but another isn't.
5. Check mail-order pharmacies: Your insurance plan's mail-order pharmacy may have access to different supply channels.

For a complete walkthrough, read our guide on how to find Mydayis in stock near you.

Final Thoughts

The Mydayis shortage in 2026 is real, but it's not as severe as it was in 2023-2024. The situation is gradually improving thanks to increased DEA quotas and additional generic competition. Still, finding Mydayis requires persistence and planning.

If you can't find Mydayis at all, your prescriber can help you explore alternative ADHD medications like Adderall XR, Vyvanse, or Concerta. These are well-established treatments that can bridge the gap until Mydayis supply stabilizes.

Stay informed, use the right tools, and work closely with your healthcare team. You have more options than you might think.